Global Cell and Gene Therapy Supply, Demand and Key Producers, 2024-2030

Description

The global Cell and Gene Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.

This report studies the global Cell and Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy total market, 2019-2030, (USD Million)
Global Cell and Gene Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell and Gene Therapy total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy revenue by player and market share 2019-2024, (USD Million)
Global Cell and Gene Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell and Gene Therapy total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cell and Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG and Orchard Therapeutics plc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell and Gene Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy Market, Segmentation by Type
    Rare Diseases
    Oncology
    Hematology
    Cardiovascular
    Ophthalmology
    Neurology
    Other Therapeutic Classes

Global Cell and Gene Therapy Market, Segmentation by Application
    Pharmaceutical and Biotechnology Companies
    Research and Academic Institutions
    Contract Research Organizations (CROs)
    Hospital
    Others

Companies Profiled:
    Amgen Inc.
    bluebird bio, Inc.
    Dendreon Pharmaceuticals LLC.
    Fibrocell Science, Inc.
    Human Stem Cells Institute
    Kite Pharma, Inc.
    Kolon TissueGene, Inc.
    Novartis AG
    Orchard Therapeutics plc.
    Organogenesis Holdings Inc.
    Pfizer, Inc.
    RENOVA THERAPEUTICS
    Shanghai Sunway Biotech Co., Ltd.,
    Sibiono GeneTech Co. Ltd.,
    Spark Therapeutics, Inc.
    Vericel Corporation
    ViroMed Co., Ltd.

Key Questions Answered
1. How big is the global Cell and Gene Therapy market?
2. What is the demand of the global Cell and Gene Therapy market?
3. What is the year over year growth of the global Cell and Gene Therapy market?
4. What is the total value of the global Cell and Gene Therapy market?
5. Who are the major players in the global Cell and Gene Therapy market?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Introduction
    1.2 World Cell and Gene Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell and Gene Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cell and Gene Therapy Market Size (2019-2030)
        1.3.3 China Cell and Gene Therapy Market Size (2019-2030)
        1.3.4 Europe Cell and Gene Therapy Market Size (2019-2030)
        1.3.5 Japan Cell and Gene Therapy Market Size (2019-2030)
        1.3.6 South Korea Cell and Gene Therapy Market Size (2019-2030)
        1.3.7 ASEAN Cell and Gene Therapy Market Size (2019-2030)
        1.3.8 India Cell and Gene Therapy Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell and Gene Therapy Major Market Trends

2 Demand Summary
    2.1 World Cell and Gene Therapy Consumption Value (2019-2030)
    2.2 World Cell and Gene Therapy Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Cell and Gene Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell and Gene Therapy Consumption Value (2019-2030)
    2.4 China Cell and Gene Therapy Consumption Value (2019-2030)
    2.5 Europe Cell and Gene Therapy Consumption Value (2019-2030)
    2.6 Japan Cell and Gene Therapy Consumption Value (2019-2030)
    2.7 South Korea Cell and Gene Therapy Consumption Value (2019-2030)
    2.8 ASEAN Cell and Gene Therapy Consumption Value (2019-2030)
    2.9 India Cell and Gene Therapy Consumption Value (2019-2030)

3 World Cell and Gene Therapy Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy in 2023
    3.3 Cell and Gene Therapy Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Market: Region Footprint
        3.4.2 Cell and Gene Therapy Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell and Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell and Gene Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell and Gene Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Revenue, (2019-2024)
    4.4 China Based Companies Cell and Gene Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell and Gene Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Cell and Gene Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell and Gene Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Rare Diseases
        5.2.2 Oncology
        5.2.3 Hematology
        5.2.4 Cardiovascular
        5.2.5 Ophthalmology
        5.2.6 Neurology
        5.2.7 Other Therapeutic Classes
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Market Size by Type (2019-2024)
        5.3.2 World Cell and Gene Therapy Market Size by Type (2025-2030)
        5.3.3 World Cell and Gene Therapy Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical and Biotechnology Companies
        6.2.2 Research and Academic Institutions
        6.2.3 Contract Research Organizations (CROs)
        6.2.4 Hospital
        6.2.5 Hospital
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy Market Size by Application (2019-2024)
        6.3.2 World Cell and Gene Therapy Market Size by Application (2025-2030)
        6.3.3 World Cell and Gene Therapy Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Amgen Inc.
        7.1.1 Amgen Inc. Details
        7.1.2 Amgen Inc. Major Business
        7.1.3 Amgen Inc. Cell and Gene Therapy Product and Services
        7.1.4 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Amgen Inc. Recent Developments/Updates
        7.1.6 Amgen Inc. Competitive Strengths & Weaknesses
    7.2 bluebird bio, Inc.
        7.2.1 bluebird bio, Inc. Details
        7.2.2 bluebird bio, Inc. Major Business
        7.2.3 bluebird bio, Inc. Cell and Gene Therapy Product and Services
        7.2.4 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 bluebird bio, Inc. Recent Developments/Updates
        7.2.6 bluebird bio, Inc. Competitive Strengths & Weaknesses
    7.3 Dendreon Pharmaceuticals LLC.
        7.3.1 Dendreon Pharmaceuticals LLC. Details
        7.3.2 Dendreon Pharmaceuticals LLC. Major Business
        7.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Services
        7.3.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Dendreon Pharmaceuticals LLC. Recent Developments/Updates
        7.3.6 Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
    7.4 Fibrocell Science, Inc.
        7.4.1 Fibrocell Science, Inc. Details
        7.4.2 Fibrocell Science, Inc. Major Business
        7.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Product and Services
        7.4.4 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Fibrocell Science, Inc. Recent Developments/Updates
        7.4.6 Fibrocell Science, Inc. Competitive Strengths & Weaknesses
    7.5 Human Stem Cells Institute
        7.5.1 Human Stem Cells Institute Details
        7.5.2 Human Stem Cells Institute Major Business
        7.5.3 Human Stem Cells Institute Cell and Gene Therapy Product and Services
        7.5.4 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Human Stem Cells Institute Recent Developments/Updates
        7.5.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
    7.6 Kite Pharma, Inc.
        7.6.1 Kite Pharma, Inc. Details
        7.6.2 Kite Pharma, Inc. Major Business
        7.6.3 Kite Pharma, Inc. Cell and Gene Therapy Product and Services
        7.6.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Kite Pharma, Inc. Recent Developments/Updates
        7.6.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
    7.7 Kolon TissueGene, Inc.
        7.7.1 Kolon TissueGene, Inc. Details
        7.7.2 Kolon TissueGene, Inc. Major Business
        7.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Product and Services
        7.7.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Kolon TissueGene, Inc. Recent Developments/Updates
        7.7.6 Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
    7.8 Novartis AG
        7.8.1 Novartis AG Details
        7.8.2 Novartis AG Major Business
        7.8.3 Novartis AG Cell and Gene Therapy Product and Services
        7.8.4 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Novartis AG Recent Developments/Updates
        7.8.6 Novartis AG Competitive Strengths & Weaknesses
    7.9 Orchard Therapeutics plc.
        7.9.1 Orchard Therapeutics plc. Details
        7.9.2 Orchard Therapeutics plc. Major Business
        7.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Product and Services
        7.9.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Orchard Therapeutics plc. Recent Developments/Updates
        7.9.6 Orchard Therapeutics plc. Competitive Strengths & Weaknesses
    7.10 Organogenesis Holdings Inc.
        7.10.1 Organogenesis Holdings Inc. Details
        7.10.2 Organogenesis Holdings Inc. Major Business
        7.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Product and Services
        7.10.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Organogenesis Holdings Inc. Recent Developments/Updates
        7.10.6 Organogenesis Holdings Inc. Competitive Strengths & Weaknesses
    7.11 Pfizer, Inc.
        7.11.1 Pfizer, Inc. Details
        7.11.2 Pfizer, Inc. Major Business
        7.11.3 Pfizer, Inc. Cell and Gene Therapy Product and Services
        7.11.4 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Pfizer, Inc. Recent Developments/Updates
        7.11.6 Pfizer, Inc. Competitive Strengths & Weaknesses
    7.12 RENOVA THERAPEUTICS
        7.12.1 RENOVA THERAPEUTICS Details
        7.12.2 RENOVA THERAPEUTICS Major Business
        7.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Product and Services
        7.12.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 RENOVA THERAPEUTICS Recent Developments/Updates
        7.12.6 RENOVA THERAPEUTICS Competitive Strengths & Weaknesses
    7.13 Shanghai Sunway Biotech Co., Ltd.,
        7.13.1 Shanghai Sunway Biotech Co., Ltd., Details
        7.13.2 Shanghai Sunway Biotech Co., Ltd., Major Business
        7.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Services
        7.13.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Developments/Updates
        7.13.6 Shanghai Sunway Biotech Co., Ltd., Competitive Strengths & Weaknesses
    7.14 Sibiono GeneTech Co. Ltd.,
        7.14.1 Sibiono GeneTech Co. Ltd., Details
        7.14.2 Sibiono GeneTech Co. Ltd., Major Business
        7.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Services
        7.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Sibiono GeneTech Co. Ltd., Recent Developments/Updates
        7.14.6 Sibiono GeneTech Co. Ltd., Competitive Strengths & Weaknesses
    7.15 Spark Therapeutics, Inc.
        7.15.1 Spark Therapeutics, Inc. Details
        7.15.2 Spark Therapeutics, Inc. Major Business
        7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Product and Services
        7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Spark Therapeutics, Inc. Recent Developments/Updates
        7.15.6 Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
    7.16 Vericel Corporation
        7.16.1 Vericel Corporation Details
        7.16.2 Vericel Corporation Major Business
        7.16.3 Vericel Corporation Cell and Gene Therapy Product and Services
        7.16.4 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Vericel Corporation Recent Developments/Updates
        7.16.6 Vericel Corporation Competitive Strengths & Weaknesses
    7.17 ViroMed Co., Ltd.
        7.17.1 ViroMed Co., Ltd. Details
        7.17.2 ViroMed Co., Ltd. Major Business
        7.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Product and Services
        7.17.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 ViroMed Co., Ltd. Recent Developments/Updates
        7.17.6 ViroMed Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Industry Chain
    8.2 Cell and Gene Therapy Upstream Analysis
    8.3 Cell and Gene Therapy Midstream Analysis
    8.4 Cell and Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell and Gene Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cell and Gene Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cell and Gene Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cell and Gene Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cell and Gene Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell and Gene Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cell and Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cell and Gene Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cell and Gene Therapy Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cell and Gene Therapy Players in 2023
    Table 12. World Cell and Gene Therapy Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cell and Gene Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Cell and Gene Therapy Player
    Table 15. Cell and Gene Therapy Market: Company Product Type Footprint
    Table 16. Cell and Gene Therapy Market: Company Product Application Footprint
    Table 17. Cell and Gene Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Cell and Gene Therapy Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cell and Gene Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cell and Gene Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell and Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cell and Gene Therapy Revenue Market Share (2019-2024)
    Table 23. China Based Cell and Gene Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell and Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cell and Gene Therapy Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cell and Gene Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell and Gene Therapy Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cell and Gene Therapy Revenue Market Share (2019-2024)
    Table 29. World Cell and Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cell and Gene Therapy Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cell and Gene Therapy Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cell and Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cell and Gene Therapy Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cell and Gene Therapy Market Size by Application (2025-2030) & (USD Million)
    Table 35. Amgen Inc. Basic Information, Area Served and Competitors
    Table 36. Amgen Inc. Major Business
    Table 37. Amgen Inc. Cell and Gene Therapy Product and Services
    Table 38. Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Amgen Inc. Recent Developments/Updates
    Table 40. Amgen Inc. Competitive Strengths & Weaknesses
    Table 41. bluebird bio, Inc. Basic Information, Area Served and Competitors
    Table 42. bluebird bio, Inc. Major Business
    Table 43. bluebird bio, Inc. Cell and Gene Therapy Product and Services
    Table 44. bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. bluebird bio, Inc. Recent Developments/Updates
    Table 46. bluebird bio, Inc. Competitive Strengths & Weaknesses
    Table 47. Dendreon Pharmaceuticals LLC. Basic Information, Area Served and Competitors
    Table 48. Dendreon Pharmaceuticals LLC. Major Business
    Table 49. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Services
    Table 50. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Dendreon Pharmaceuticals LLC. Recent Developments/Updates
    Table 52. Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
    Table 53. Fibrocell Science, Inc. Basic Information, Area Served and Competitors
    Table 54. Fibrocell Science, Inc. Major Business
    Table 55. Fibrocell Science, Inc. Cell and Gene Therapy Product and Services
    Table 56. Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Fibrocell Science, Inc. Recent Developments/Updates
    Table 58. Fibrocell Science, Inc. Competitive Strengths & Weaknesses
    Table 59. Human Stem Cells Institute Basic Information, Area Served and Competitors
    Table 60. Human Stem Cells Institute Major Business
    Table 61. Human Stem Cells Institute Cell and Gene Therapy Product and Services
    Table 62. Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Human Stem Cells Institute Recent Developments/Updates
    Table 64. Human Stem Cells Institute Competitive Strengths & Weaknesses
    Table 65. Kite Pharma, Inc. Basic Information, Area Served and Competitors
    Table 66. Kite Pharma, Inc. Major Business
    Table 67. Kite Pharma, Inc. Cell and Gene Therapy Product and Services
    Table 68. Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Kite Pharma, Inc. Recent Developments/Updates
    Table 70. Kite Pharma, Inc. Competitive Strengths & Weaknesses
    Table 71. Kolon TissueGene, Inc. Basic Information, Area Served and Competitors
    Table 72. Kolon TissueGene, Inc. Major Business
    Table 73. Kolon TissueGene, Inc. Cell and Gene Therapy Product and Services
    Table 74. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Kolon TissueGene, Inc. Recent Developments/Updates
    Table 76. Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
    Table 77. Novartis AG Basic Information, Area Served and Competitors
    Table 78. Novartis AG Major Business
    Table 79. Novartis AG Cell and Gene Therapy Product and Services
    Table 80. Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Novartis AG Recent Developments/Updates
    Table 82. Novartis AG Competitive Strengths & Weaknesses
    Table 83. Orchard Therapeutics plc. Basic Information, Area Served and Competitors
    Table 84. Orchard Therapeutics plc. Major Business
    Table 85. Orchard Therapeutics plc. Cell and Gene Therapy Product and Services
    Table 86. Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Orchard Therapeutics plc. Recent Developments/Updates
    Table 88. Orchard Therapeutics plc. Competitive Strengths & Weaknesses
    Table 89. Organogenesis Holdings Inc. Basic Information, Area Served and Competitors
    Table 90. Organogenesis Holdings Inc. Major Business
    Table 91. Organogenesis Holdings Inc. Cell and Gene Therapy Product and Services
    Table 92. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Organogenesis Holdings Inc. Recent Developments/Updates
    Table 94. Organogenesis Holdings Inc. Competitive Strengths & Weaknesses
    Table 95. Pfizer, Inc. Basic Information, Area Served and Competitors
    Table 96. Pfizer, Inc. Major Business
    Table 97. Pfizer, Inc. Cell and Gene Therapy Product and Services
    Table 98. Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Pfizer, Inc. Recent Developments/Updates
    Table 100. Pfizer, Inc. Competitive Strengths & Weaknesses
    Table 101. RENOVA THERAPEUTICS Basic Information, Area Served and Competitors
    Table 102. RENOVA THERAPEUTICS Major Business
    Table 103. RENOVA THERAPEUTICS Cell and Gene Therapy Product and Services
    Table 104. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. RENOVA THERAPEUTICS Recent Developments/Updates
    Table 106. RENOVA THERAPEUTICS Competitive Strengths & Weaknesses
    Table 107. Shanghai Sunway Biotech Co., Ltd., Basic Information, Area Served and Competitors
    Table 108. Shanghai Sunway Biotech Co., Ltd., Major Business
    Table 109. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Services
    Table 110. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Shanghai Sunway Biotech Co., Ltd., Recent Developments/Updates
    Table 112. Shanghai Sunway Biotech Co., Ltd., Competitive Strengths & Weaknesses
    Table 113. Sibiono GeneTech Co. Ltd., Basic Information, Area Served and Competitors
    Table 114. Sibiono GeneTech Co. Ltd., Major Business
    Table 115. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Services
    Table 116. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Sibiono GeneTech Co. Ltd., Recent Developments/Updates
    Table 118. Sibiono GeneTech Co. Ltd., Competitive Strengths & Weaknesses
    Table 119. Spark Therapeutics, Inc. Basic Information, Area Served and Competitors
    Table 120. Spark Therapeutics, Inc. Major Business
    Table 121. Spark Therapeutics, Inc. Cell and Gene Therapy Product and Services
    Table 122. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Spark Therapeutics, Inc. Recent Developments/Updates
    Table 124. Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
    Table 125. Vericel Corporation Basic Information, Area Served and Competitors
    Table 126. Vericel Corporation Major Business
    Table 127. Vericel Corporation Cell and Gene Therapy Product and Services
    Table 128. Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Vericel Corporation Recent Developments/Updates
    Table 130. ViroMed Co., Ltd. Basic Information, Area Served and Competitors
    Table 131. ViroMed Co., Ltd. Major Business
    Table 132. ViroMed Co., Ltd. Cell and Gene Therapy Product and Services
    Table 133. ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 134. Global Key Players of Cell and Gene Therapy Upstream (Raw Materials)
    Table 135. Cell and Gene Therapy Typical Customers
List of Figure
    Figure 1. Cell and Gene Therapy Picture
    Figure 2. World Cell and Gene Therapy Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cell and Gene Therapy Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cell and Gene Therapy Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell and Gene Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cell and Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cell and Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cell and Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cell and Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cell and Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cell and Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cell and Gene Therapy Revenue (2019-2030) & (USD Million)
    Figure 13. Cell and Gene Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cell and Gene Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cell and Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cell and Gene Therapy by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Markets in 2023
    Figure 27. United States VS China: Cell and Gene Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cell and Gene Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cell and Gene Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cell and Gene Therapy Market Size Market Share by Type in 2023
    Figure 31. Rare Diseases
    Figure 32. Oncology
    Figure 33. Hematology
    Figure 34. Cardiovascular
    Figure 35. Ophthalmology
    Figure 36. Neurology
    Figure 37. Other Therapeutic Classes
    Figure 38. World Cell and Gene Therapy Market Size Market Share by Type (2019-2030)
    Figure 39. World Cell and Gene Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Cell and Gene Therapy Market Size Market Share by Application in 2023
    Figure 41. Pharmaceutical and Biotechnology Companies
    Figure 42. Research and Academic Institutions
    Figure 43. Contract Research Organizations (CROs)
    Figure 44. Hospital
    Figure 45. Others
    Figure 46. Cell and Gene Therapy Industrial Chain
    Figure 47. Methodology
    Figure 48. Research Process and Data Source

Companies Mentioned

Amgen Inc.
bluebird bio, Inc.
Dendreon Pharmaceuticals LLC.
Fibrocell Science, Inc.
Human Stem Cells Institute
Kite Pharma, Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Organogenesis Holdings Inc.
Pfizer, Inc.
RENOVA THERAPEUTICS
Shanghai Sunway Biotech Co., Ltd.,
Sibiono GeneTech Co. Ltd.,
Spark Therapeutics, Inc.
Vericel Corporation
ViroMed Co., Ltd.